Kala Bio (KALA) Non Operating Interest Expenses (2016 - 2025)

Kala Bio has disclosed Non Operating Interest Expenses across 10 years of filings, most recently posting $141000.0 for Q4 2025.

• In Q4 2025, Non Operating Interest Expenses fell 89.87% year-over-year to $141000.0; the TTM figure through Dec 2025 stood at $3.3 million (down 43.35% YoY), while the FY2025 annual figure was $3.3 million, down 43.35% from the prior year.
• Non Operating Interest Expenses came in at $141000.0 for Q4 2025 at Kala Bio, down from $963000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $2.2 million in Q2 2022 to a low of $141000.0 in Q4 2025.
• Average Non Operating Interest Expenses over 5 years is $1.5 million, with a median of $1.5 million recorded in 2023.
• Year-over-year, Non Operating Interest Expenses gained 5.55% in 2022 and plunged 89.87% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $2.1 million in 2021, then slipped by 24.04% to $1.6 million in 2022, then decreased by 6.91% to $1.5 million in 2023, then retreated by 5.18% to $1.4 million in 2024, then sank by 89.87% to $141000.0 in 2025.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $141000.0 in Q4 2025, $963000.0 in Q3 2025, and $1.1 million in Q2 2025.